Theracurmin for ALS
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests Theracurmin HP, a form of curcumin (a compound in turmeric), to determine its potential benefits for people with Amyotrophic Lateral Sclerosis (ALS), a disease affecting nerve cells in the brain and spinal cord. Participants will take Theracurmin capsules twice daily for six months. The trial will compare results from people with ALS to healthy control participants to identify any differences. Individuals diagnosed with ALS who can use a computer and are not currently taking other experimental ALS treatments might be suitable for this study. As a Phase 2 trial, this research focuses on assessing the treatment's effectiveness in an initial, smaller group of people.
Will I have to stop taking my current medications?
The trial does not specify if you need to stop taking your current medications, but you cannot participate if you are taking experimental ALS treatments or antiplatelet or anticoagulant medications.
Is there any evidence suggesting that Theracurmin HP is likely to be safe for humans?
Research has shown that Theracurmin HP, a special type of curcumin, has been tested for safety in people. In earlier studies, healthy adults took doses similar to those planned for this trial, and the treatment was well-tolerated with no major side effects. Theracurmin HP is generally safe for regular use, but individuals with conditions like gallstones or bile duct problems should exercise caution.
Although earlier studies demonstrated the treatment's safety, this trial is still investigating its use for ALS. Prospective participants should consult healthcare professionals to ensure the trial is suitable for them.12345Why do researchers think this study treatment might be promising?
Unlike the standard ALS treatments, which typically focus on managing symptoms or slowing disease progression through medications like riluzole and edaravone, Theracurmin HP offers a unique approach by utilizing curcumin, a compound derived from turmeric. Curcumin is known for its anti-inflammatory and antioxidant properties, which might provide new pathways for slowing ALS progression. Researchers are excited about Theracurmin because it uses an enhanced bioavailable form, making it easier for the body to absorb and potentially more effective at delivering these benefits. The hope is that it can offer a safer, more natural alternative with fewer side effects.
What evidence suggests that Theracurmin HP might be an effective treatment for mild cognitive impairment?
Research shows that Theracurmin, a type of curcumin, may help improve brain function. Studies have found that curcumin can enhance memory and attention in adults without dementia and is linked to better brain health related to memory. In this trial, participants in the experimental arm will receive Theracurmin HP to explore its potential effects on ALS. Although no direct evidence exists for its effects on ALS, the positive impact on brain function suggests it might help with conditions like ALS. The potential of curcumin to boost brain health offers hope for treating ALS symptoms.678910
Who Is on the Research Team?
Richard Bedlack, MD, PhD
Principal Investigator
Duke University
Are You a Good Fit for This Trial?
Inclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants take Theracurmin 1 capsule (90mg) twice daily for 6 months
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- Theracurmin HP
Find a Clinic Near You
Who Is Running the Clinical Trial?
Richard Bedlack, M.D., Ph.D.
Lead Sponsor